Impact of herpes simplex virus type 2 on HIV-1 acquisition and progression in an HIV vaccine trial (the step study)

Journal of Acquired Immune Deficiency Syndromes

Volumn 57, Issue 3, 2011, Pages 238-244

  Barnabas, Ruanne V ^a,b   Wasserheit, Judith N ^a,b   Huang, Yunda ^a   Janes, Holly ^a,b   Morrow, Rhoda ^a   Fuchs, Jonathan ^c   Mark, Karen E ^a,b,e   Casapia, Martin ^d   Mehrotra, Devan V ^f   Buchbinder, Susan P ^c   Corey, Lawrence ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c San Francisco Department of Health   (United States)

^d ASOCIACIÓN CIVIL SELVA AMAZÓNICA   (Peru)

^e MERCK RESEARCH LABORATORIES   (United States)

^f Office of AIDS   (United States)

Author keywords

herpes simplex virus type 2; HIV incidence

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADULT; ANALYSIS; ARTICLE; CIRCUMCISION; CLINICAL EXAMINATION; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; DOUBLE BLIND PROCEDURE; HERPES SIMPLEX VIRUS 2; HERPES VIRUS INFECTION; HIGH RISK BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION RISK; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MULTICENTER STUDY; NONHUMAN; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; VIRUS LOAD;

EID: 85027927845     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31821acb5     Document Type: Article

References (53)

1. Looker KJ, Garnett GP, Schmid GP. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Organ. 2008;86:805-812, A.
2. Weiss H. Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes. 2004;11(Suppl 1):A24-A35.
3. Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA. 2006;296: 964-973. (Pubitemid 44285373)
4. Lama JR, Lucchetti A, Suarez L, et al. Association of herpes simplex virus type 2 infection and syphilis with human immunodeficiency virus infection among men who have sex with men in Peru. J Infect Dis. 2006; 194:1459-1466. (Pubitemid 44706516)
5. Corey L, Wald A. Genital herpes. In: Holmes KK, Sparling PF, Stamm WE, et al, eds. Sexually Transmitted Diseases. 4th ed. New York, NY: McGraw-Hill; 2008.
6. Wald A, Zeh J, Selke S, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med. 2000;342:844-850. (Pubitemid 30165207)
7. Mark KE, Wald A, Magaret AS, et al. Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults. J Infect Dis. 2008; 198:1141-1149.
8. Corey L, Woodward A, Klock A, et al. Genital HSV-2 infection imprints a marked enrichment and long term persistence of HIV receptor positive cells in the genital tract: implications for microbicide and vaccine studies. Paper presented at: Keystone Symposia: Prevention of HIV/AIDS March 22-March 27, 2009;Keystone, Colorado, Plenary Presentation.
9. Schiffer JT, Abu-Raddad L, Mark EK, et al. Frequent release of low amounts of herpes simplex virus from neurons: results of a mathematical model. Sci Transl Med. 2009;1:7ra16.
10. Mertz GJ, Benedetti J, Ashley R, et al. Risk factors for the sexual transmission of genital herpes. Ann Intern Med. 1992;116:197-202.
11. Corey L, Wald A, Celum CL, et al. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr. 2004;35:435-445. (Pubitemid 38420652)
12. Wald A, Corey L. How does herpes simplex virus type 2 influence human immunodeficiency virus infection and pathogenesis? J Infect Dis. 2003; 187:1509-1512. (Pubitemid 36578956)
13. Celum C, Levine R, Weaver M, et al. Genital herpes and human immunodeficiency virus: double trouble. Bull World Health Organ. 2004; 82:447-453. (Pubitemid 38828431)
14. Wasserheit JN. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis. 1992;19:61-77. (Pubitemid 23101885)
15. Freeman EE, Weiss HA, Glynn JR, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS. 2006;20:73-83. (Pubitemid 41818117)
16. Sobngwi-Tambekou J, Taljaard D, Lissouba P, et al. Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange Farm, South Africa. J Infect Dis. 2009; 199:958-964.
17. Mahiane SG, Legeai C, Taljaard D, et al. Transmission probabilities of HIV and herpes simplex virus type 2, effect of male circumcision and interaction: a longitudinal study in a township of South Africa. AIDS. 2009;23:377-383.
18. Duffus WA, Mermin J, Bunnell R, et al. Chronic herpes simplex virus type-2 infection and HIV viral load. Int J STD AIDS. 2005;16:733-735. (Pubitemid 41659532)
19. Gray RH, Li X, Wawer MJ, et al. Determinants of HIV-1 load in subjects with early and later HIV infections, in a general-population cohort of Rakai, Uganda. J Infect Dis. 2004;189:1209-1215. (Pubitemid 38457245)
20. Mole L, Ripich S, Margolis D, et al. The impact of active herpes simplex virus infection on human immunodeficiency virus load. J Infect Dis. 1997; 176:766-770. (Pubitemid 27360547)
21. Serwadda D, Gray RH, Sewankambo NK, et al. Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda. J Infect Dis. 2003;188:1492-1497. (Pubitemid 37523934)
22. Schacker T, Zeh J, Hu H, et al. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J Infect Dis. 2002;186:1718-1725. (Pubitemid 35463503)
23. Mellors JW, Kingsley LA, Rinaldo CR Jr, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med. 1995;122:573-579.
24. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med. 2000;342:921-929. (Pubitemid 30177052)
25. Celum C,Wald A, Hughes J, et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet. 2008; 371:2109-2119. (Pubitemid 351902179)
26. Celum C, Wald A, Lingappa JR, et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med. 2010; 362:427-439.
27. Watson-Jones D, Weiss HA, Rusizoka M, et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med. 2008;358:1560-1571. (Pubitemid 351519816)
28. Zhu J, Hladik F,Woodward A, et al. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV- 1 acquisition. Nat Med. 2009;15:886-892.
29. Buchbinder SP, Mehrotra DV, Duerr A, et al. Efficacy assessment of a cellmediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet. 2008;372: 1881-1893.
30. Duerr A, Huang Y, Buchbinder S, et al. Analysis of the relative risk of HIV acquisition among Step study participants with extended followup. Presented at: AIDS Vaccine 2010; September 29, 2010; Atlanta, Georgia.
31. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents 2011. Available at: http://www.aidsinfo.nih.gov/Content- Files/ AdultandAdolescentGL.pdf. Accessed February 15, 2011.
32. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach- 2010 rev. Geneva, Switzerland 2010. Available at: http://whqlibdoc. who.int/publications/ 2010/9789241599764-eng.pdf. Accessed February 15, 2011.
33. Hammer SM, Eron JJ Jr, Reiss P, et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA. 2008;300:555-570.
34. Ashley RL, Militoni J, Lee F, et al. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol. 1988;26:662-667. (Pubitemid 18087189)
35. Venables WN, Ripley BD. Modern Applied Statistics With S. New York, NY, 4th ed: Springer; 2002.
36. Stata/SE 10.0 [computer program], StataCorp LP. College Station, TX; 2007.
37. Grambsch P, Therneau T. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515-526.
38. Rubin DB. Multiple Imputation for Nonresponse in Surveys. Hoboken, NJ: John Wiley and Sons; 1987.
39. van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res. 2007;16: 219-242.
40. Tabet SR, Krone MR, Paradise MA, et al. Incidence of HIV and sexually transmitted diseases (STD) in a cohort of HIV-negative men who have sex with men (MSM). AIDS. 1998;12:2041-2048. (Pubitemid 28479281)
41. Renzi C, Douglas JM Jr, Foster M, et al. Herpes simplex virus type 2 infection as a risk factor for human immunodeficiency virus acquisition in men who have sex with men. J Infect Dis. 2003;187:19-25. (Pubitemid 36034467)
42. Weiss HA, Thomas SL, Munabi SK, et al. Male circumcision and risk of syphilis, chancroid, and genital herpes: a systematic review and metaanalysis. Sex Transm Infect. 2006;82:101-109; discussion 110.
43. Tobian AA, Serwadda D, Quinn TC, et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med. 2009;360:1298-1309.
44. Millett GA, Flores SA, Marks G, et al. Circumcision status and risk of HIV and sexually transmitted infections among men who have sex with men: a meta-analysis. JAMA. 2008;300:1674-1684.
45. Kreiss JK, Hopkins SG. The association between circumcision status and human immunodeficiency virus infection among homosexual men. J Infect Dis. 1993;168:1404-1408. (Pubitemid 23344898)
46. Sanchez J. Cutting the edge of the HIV epidemic among MSM. Presented at: The Center for HIV Identification, Prevention and Treatment Services (CHIPTS). The Future Direction of Male Circumcision in HIV Prevention Working Conference; April 9, 2007; Los Angeles, CA.
47. Templeton DJ, Jin F, Prestage GP, et al. Circumcision and risk of sexually transmitted diseases in the HIM cohort of homosexual men in Sydney, Australia. Presented at: The International Society for Sexually Transmitted Disease Research. July 30, 2007; Seattle, WA.
48. Templeton DJ, Mao L, Prestage G, et al. Demographic predictors of circumcision status in a community-based sample of homosexual men in Sydney, Australia. Sex Health. 2006;3:191-193. (Pubitemid 44325581)
49. Brown EL, Wald A, Hughes JP, et al. High risk of human immunodeficiency virus in men who have sex with men with herpes simplex virus type 2 in the EXPLORE study. Am J Epidemiol. 2006;164: 733-741. (Pubitemid 44522078)
50. Celum CL. The interaction between herpes simplex virus and human immunodeficiency virus. Herpes. 2004;11(suppl 1):A36-A45.
51. Palu G, Benetti L, Calistri A. Molecular basis of the interactions between herpes simplex viruses and HIV-1. Herpes. 2001;8:50-55. (Pubitemid 32625616)
52. Barnabas RV, Weiss HA, Wasserheit JN. Role of co-infections in HIV epidemic trajectory and positive prevention: a systematic review and meta-analysis of malaria, HSV-2 and TB co-infections. ISSTDR Conference; July 1, 2009; London, United Kingdom.
53. Ioannidis JP, Collier AC, Cooper DA, et al. Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data. J Infect Dis. 1998; 178:349-359. (Pubitemid 28347916)